BOFLOX 100 mg/ml
BOFLOX 100 mg/ml
Not authorised
- Marbofloxacin
Product identification
Medicine name:
BOFLOX 100 mg/ml
Active substance:
- Marbofloxacin
Target species:
-
Cattle
-
Pig (sow)
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Marbofloxacin100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offalno withdrawal periodMeat and offal: 6 days 2 mg (IV/SC/IM) /3 days 8 mg (IM); Milk:36 hours 2 mg (IV/SC/IM) / 72 hours 8 mg (IM)
-
-
Pig (sow)
-
Meat and offal4day
-
-
Cattle
-
Milkno withdrawal periodMeat and offal: 6 days 2 mg (IV/SC/IM) /3 days 8 mg (IM); Milk:36 hours 2 mg (IV/SC/IM) / 72 hours 8 mg (IM)
-
-
-
Intravenous use
-
Cattle
-
Meat and offalno withdrawal periodMeat and offal: 6 days 2 mg (IV/SC/IM) /3 days 8 mg (IM); Milk:36 hours 2 mg (IV/SC/IM) / 72 hours 8 mg (IM)
-
-
Cattle
-
Milkno withdrawal periodMeat and offal: 6 days 2 mg (IV/SC/IM) /3 days 8 mg (IM); Milk:36 hours 2 mg (IV/SC/IM) / 72 hours 8 mg (IM)
-
-
-
Subcutaneous use
-
Cattle
-
Meat and offalno withdrawal periodMeat and offal: 6 days 2 mg (IV/SC/IM) /3 days 8 mg (IM); Milk:36 hours 2 mg (IV/SC/IM) / 72 hours 8 mg (IM)
-
-
Cattle
-
Milkno withdrawal periodMeat and offal: 6 days 2 mg (IV/SC/IM) /3 days 8 mg (IM); Milk:36 hours 2 mg (IV/SC/IM) / 72 hours 8 mg (IM)
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01MA93
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Revoked
Authorised in:
-
Luxembourg
Package description:
- cardboard box containing 12 vials of 250 ml
- cardboard box containing 12 vials of 100 ml
- cardboard box containing 10 vials of 250 ml
- cardboard box containing 10 vials of 100 ml
- cardboard box containing 6 vials of 250 ml
- cardboard box containing 6 vials of 100 ml
- cardboard box containing 1 vial of 250 ml
- cardboard box containing 1 vial of 100 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Industrial Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Industrial Veterinaria S.A.
- KELA Kempisch Laboratorium Kela Laboratoria
- aniMedica GmbH
Responsible authority:
- Ministry Of Health And Social Security
Authorisation number:
- V 054/13/12/2115
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0190/001
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
